Pulmonary vascular diseases
Sleep and breathing disorders
Thoracic oncology
Oral presentation
Obstructive sleep apnea consequences and management
Methods :
Epidemiology, Imaging, Physiology
11:15
Long-term effect of OSA and CPAP on blood pressure in patients with acute coronary syndrome: A post-hoc analysis of the ISAACC study.
M. Sanchez De La Torre(Toledo, Spain)
COI
1
11:20
Percentage of sleep time with increase in respiratory effort is a strong predictor of prevalent hypertension in obstructive sleep apnea patients
J. Pépin(Grenoble, France)
COI
2
11:25
Pulse wave amplitude drops (PWAD) index: a biomarker of cardiovascular risk in patients with obstructive sleep apnea in three cohorts.
R. Heinzer(Lausanne, Switzerland)
COI
3
11:30
The effect of CPAP therapy on aortic inflammation in obstructive sleep apnoea: data from a proof-of-concept PET-CT study
C. O'Donnell(Dublin 4, Ireland)
COI
4
11:35
Impact of sulthiame on endotypic traits in OSA - a RCT
J. Hedner(Göteborg, Sweden)
COI
5
11:40
Obstructive sleep apnea and cognitive decline in the elderly population: the HypnoLaus study
R. Heinzer(Lausanne, Switzerland)
COI
6
11:45
Sleep apnea and incident unprovoked venous thromboembolism: Data from the French Pays de la Loire Sleep Cohort
W. Trzepizur(Angers, France)
COI
7
11:50
Sleep characteristics and cardio-metabolic comorbidities in the OSA-COPD overlap syndrome: Data from the European Sleep Apnea Database (ESADA)
M. van Zeller(Porto, Portugal)
COI
8
11:55
Cancer prevalence is increased in obstructive sleep apnea – the population-based DISCOVERY study
A. Palm(Uppsala, Sweden)
COI
9
12:00
Late Breaking Abstract - Predictors of BP reduction in patients with OSA treated with CPAP therapy – an individual patient data meta-analysis
M. Pengo(Milano (MI), Italy)
COI
10
12:05
Discussion
11
OA2292
. . .
